Dr. Berendt is a seasoned executive with extensive experience in life sciences, having held senior roles at Bayer and Pfizer and served on multiple Boards. He has also worked as a venture capitalist and consultant. His expertise spans management, science, business development, and finance.

 

More On Michael Berendt

​

Eric is a proven business and legal executive with nearly 30 years of experience in life sciences-based companies. In addition to his role as Founder and CEO of Retension Pharmaceuticals, he is the Founder and CEO of Redux Therapeutics, a therapeutic asset acquisition and development company.

​

More On Eric Keller

Donald Olds is an experienced executive and corporate director with expertise in financing, business development and clinical operations. Don has held leadership roles at public and private biotechnology companies, including the NEOMED Institute, and began his career in investment banking. He holds an MBA and M.Sc. from McGill University.

​

More On Donald Olds

​

​